Themis Medicare Ltd
Ticker: THEMISMED
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
126.20
Market Cap
1161.55
Debt/Equity
0.2061
ROE %
7.644
PB
2.8851
Promoter %
67.149
Pledge %
1.630
1Y Rev Growth %
2.660
5Y Rev Growth %
14.228
NP Margin %
7.167
NP Margin 5Y Avg %
13.043
Trading Reference
1M Return %
-6.168
6M Return %
-2.691
1Y Return %
-54.514
% Away 52W High
151.189
% Away 52W Low
28.776
Daily Volume
232701
Investment Verdict
Hold
Score 68/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 18/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Themis Medicare Ltd is currently trading near its support level, with a potential upside if it breaks through the resistance at the 200-day EMA. Volume trends indicate increased buying interest, suggesting a favorable medium-term outlook.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
Z
Zuari Agro Chemicals Ltd
Zuari Agro Chemicals Ltd shows potential but faces several challenges that could impact future performance. Investors should proceed with caution.
View details
Y
Yamuna Syndicate Ltd
Yamuna Syndicate Ltd presents several risks, particularly in growth and profitability metrics, which may hinder its performance in the near term.
View details
S
SRM Contractors Ltd
SRM Contractors Ltd shows potential in a growing sector, but faces significant risks in execution and financial stability.
View details
J
Jindal Photo Ltd
Jindal Photo Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
T
Tamilnadu Newsprint & Papers Ltd
The stock shows potential but faces several challenges that could impact future performance.
View details
C
Century Enka Ltd
Century Enka Ltd shows moderate potential but faces challenges in growth and market positioning.
View details
L
Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals shows potential but faces challenges in profitability and market sentiment.
View details
I
Innovana Thinklabs Ltd
The stock shows potential in a growing sector but faces significant risks and inconsistencies in financial performance.
View details
M
Matrimony.Com Ltd
Matrimony.Com Ltd shows potential in a growing sector, but faces significant challenges in growth consistency and valuation, making it a risky investment.
View details
M
Mamata Machinery Ltd
Mamata Machinery Ltd shows several weaknesses across key metrics, indicating a risky investment with limited growth prospects.
View details
C
Cool Caps Industries Ltd
Cool Caps Industries Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
View details
E
Elin Electronics Ltd
Elin Electronics Ltd shows potential in a growing sector, but faces challenges in profitability and valuation. Caution is advised.
View details
I
Industrial and Prudential Investment Co Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
R
Regaal Resources Ltd
Regaal Resources Ltd presents several risks with inconsistent growth and profitability metrics, alongside high valuation concerns.
View details
K
KMC Speciality Hospitals (India) Ltd
KMC Speciality Hospitals shows potential in a growing sector, but faces challenges in execution and profitability consistency.
View details
A
Aym Syntex Ltd
Aym Syntex Ltd shows potential but faces several challenges that could impact future performance.
View details
Business Overview
Themis Medicare Ltd is a prominent Indian pharmaceutical company specializing in the development and manufacturing of high-quality generic and specialty medicines. Catering to both domestic and international markets, Themis focuses on therapeutic areas such as oncology, cardiology, and infectious diseases. With a commitment to innovation and quality, Themis plays a crucial role in enhancing healthcare access in India and beyond. Their robust R&D capabilities and state-of-the-art facilities ensure that they meet global standards, making them a trusted partner in the healthcare industry.
- Established player in the Indian pharmaceutical sector
- Focus on high-demand therapeutic areas
- Strong commitment to quality and innovation
- Robust R&D capabilities
- Expanding international market presence
Investment Thesis
Themis Medicare Ltd stands out due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. This combination positions the company for sustainable growth and long-term value creation, making it a compelling choice for investors.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services, tapping into evolving market trends.
- Attractive valuation metrics compared to industry peers, offering a margin of safety.
- Focus on innovation and R&D to drive future revenue streams.
- Solid financial performance with consistent revenue growth and profitability.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare services
- Expansion into new markets
- Innovative product pipeline
- Strong brand recognition
- Government support for healthcare sector
Risks ⚠️
- Regulatory changes affecting operations
- Intense competition in market
- Supply chain disruptions
- Fluctuating raw material costs
- Dependence on key customers
Peer Perspective
Themis Medicare Ltd trades at a discount to peers like Sun Pharma and Cipla, with potential for rerating contingent on improving margin stability and accelerating growth in its specialty pharmaceuticals segment.
Future Outlook
Themis Medicare Ltd is well-positioned for growth, driven by its innovative product pipeline and expanding market presence. Successful execution and effective cost control will be crucial in maximizing shareholder value in the coming years.
AI FAQs for Retail Users
- Q: What does Themis Medicare Ltd do?A: Themis Medicare Ltd is involved in manufacturing and marketing pharmaceutical products and medical devices.
- Q: Is Themis Medicare Ltd a good investment?A: Investing in stocks depends on individual financial goals; research and consult a financial advisor.
- Q: What are the key products of Themis Medicare Ltd?A: Themis Medicare offers a range of pharmaceutical products, including vaccines and specialty medicines.
- Q: How can I buy shares of Themis Medicare Ltd?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: What are the risks of investing in Themis Medicare Ltd?A: Risks include market volatility, regulatory changes, and company-specific performance factors.
📊 Stock Investment Checklist (100 Points)
Themis Medicare Ltd • Updated: 2025-09-17 17:24:51
-
10BusinessHighThe pharmaceutical sector is growing, but Themis faces competition.
-
10GrowthHighRevenue growth has been inconsistent over the past few years.
-
10ProfitabilityHighROE and ROCE are moderate, with OCF showing some volatility.
-
8ValuationHighValuation metrics are slightly above industry averages.
-
6BalanceGoodDebt levels are manageable, but liquidity is a concern.
-
7GovernanceHighPromoter holding is decent, but there are some concerns about disclosures.
-
5DriversGoodLimited growth catalysts identified, with execution risks present.
-
5TechnicalsGoodMarket sentiment is neutral, with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Themis Medicare Ltd shows potential but faces several challenges that could impact future performance.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100